Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | MCHR1 | Q99705 | 16/20 | 0.54 |
| ▸ | ADRA2A | P08913 | 12/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.49 |
| ▸ | HRH1 | P35367 | 2/20 | 0.49 |
| ▸ | HTR2B | P41595 | 2/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.49 |
| ▸ | CCR3 | P51677 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6877371 | 1.00 | NPC1 (0.61) | NPC1PKMMCHR1ADRA2AADRA1A | |
| SCHEMBL6465595 | 0.93 | MCHR1 (0.61) | NPC1MCHR1ADRA2AADRA1AHRH1 | |
| SCHEMBL6465599 | 0.93 | MCHR1 (0.61) | NPC1MCHR1ADRA2AADRA1AHRH1 | |
| SCHEMBL6457452 | 0.89 | MCHR1 (0.55) | NPC1PKMMCHR1ADRA2AADRA1A | |
| SCHEMBL6457460 | 0.89 | MCHR1 (0.55) | NPC1PKMMCHR1ADRA2AADRA1A | |
| SCHEMBL6879865 | 0.89 | MCHR1 (0.57) | MCHR1ADRA2AADRA1AHRH1HTR2B | |
| SCHEMBL6879862 | 0.89 | MCHR1 (0.57) | MCHR1ADRA2AADRA1AHRH1HTR2B | |
| SCHEMBL6873154 | 0.89 | MCHR1 (0.58) | NPC1MCHR1ADRA2AADRA1AHRH1 | |
| SCHEMBL6873148 | 0.89 | MCHR1 (0.58) | NPC1MCHR1ADRA2AADRA1AHRH1 | |
| SCHEMBL6455557 | 0.88 | MCHR1 (0.70) | NPC1MCHR1ADRA2AADRA1AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |